Logo image of GXU.CA

GOVIEX URANIUM INC (GXU.CA) Stock Fundamental Analysis

Canada - TSX-V:GXU - CA3837981057 - Common Stock

0.06 CAD
+0.01 (+20%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

2

GXU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 216 industry peers in the Oil, Gas & Consumable Fuels industry. GXU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GXU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GXU had negative earnings in the past year.
In the past year GXU has reported a negative cash flow from operations.
GXU had negative earnings in each of the past 5 years.
In the past 5 years GXU always reported negative operating cash flow.
GXU.CA Yearly Net Income VS EBIT VS OCF VS FCFGXU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

GXU's Return On Assets of -1790.73% is on the low side compared to the rest of the industry. GXU is outperformed by 92.13% of its industry peers.
The Return On Equity of GXU (-5470.67%) is worse than 82.41% of its industry peers.
Industry RankSector Rank
ROA -1790.73%
ROE -5470.67%
ROIC N/A
ROA(3y)-506.58%
ROA(5y)-308.17%
ROE(3y)-896.75%
ROE(5y)-543.55%
ROIC(3y)N/A
ROIC(5y)N/A
GXU.CA Yearly ROA, ROE, ROICGXU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K -2.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GXU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GXU.CA Yearly Profit, Operating, Gross MarginsGXU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for GXU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GXU has more shares outstanding
GXU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GXU.CA Yearly Shares OutstandingGXU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
GXU.CA Yearly Total Debt VS Total AssetsGXU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

GXU has an Altman-Z score of -122.67. This is a bad value and indicates that GXU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -122.67, GXU is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
GXU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -122.67
ROIC/WACCN/A
WACCN/A
GXU.CA Yearly LT Debt VS Equity VS FCFGXU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.19 indicates that GXU may have some problems paying its short term obligations.
GXU has a worse Current ratio (0.19) than 83.80% of its industry peers.
A Quick Ratio of 0.19 indicates that GXU may have some problems paying its short term obligations.
With a Quick ratio value of 0.19, GXU is not doing good in the industry: 83.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
GXU.CA Yearly Current Assets VS Current LiabilitesGXU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for GXU have decreased strongly by -313.85% in the last year.
EPS 1Y (TTM)-313.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, GXU will show a very strong growth in Earnings Per Share. The EPS will grow by 74.02% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2Y-14.02%
EPS Next 3Y74.02%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GXU.CA Yearly Revenue VS EstimatesGXU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 20M 40M 60M 80M 100M
GXU.CA Yearly EPS VS EstimatesGXU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 0.01 -0.01 0.02 -0.02 0.03

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GXU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GXU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GXU.CA Price Earnings VS Forward Price EarningsGXU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GXU.CA Per share dataGXU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

A more expensive valuation may be justified as GXU's earnings are expected to grow with 74.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.02%
EPS Next 3Y74.02%

More info and screens

0

5. Dividend

5.1 Amount

GXU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOVIEX URANIUM INC

TSX-V:GXU (9/19/2025, 7:00:00 PM)

0.06

+0.01 (+20%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-22 2025-08-22
Earnings (Next)11-17 2025-11-17
Inst Owners18.03%
Inst Owner ChangeN/A
Ins Owners13.98%
Ins Owner ChangeN/A
Market Cap61.32M
Analysts84.44
Price Target0.23 (283.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 37.08
P/tB 37.08
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1790.73%
ROE -5470.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-506.58%
ROA(5y)-308.17%
ROE(3y)-896.75%
ROE(5y)-543.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -122.67
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)181.36%
Cap/Depr(5y)217.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-313.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.09%
EPS Next Y0%
EPS Next 2Y-14.02%
EPS Next 3Y74.02%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.14%
EBIT Next 3Y102.6%
EBIT Next 5YN/A
FCF growth 1Y48.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.04%
OCF growth 3YN/A
OCF growth 5YN/A